LabCorp Launches New Patient-Centric Diabetes Report Read more about LabCorp Launches New Patient-Centric Diabetes Report
LabCorp Prices $500,000,000 in 2.625% Senior Notes Due 2020, $500,000,000 in 3.200% Senior Notes Due 2022, $1,000,000,000 in 3.600% Senior Notes Due 2025 and $900,000,000 in 4.700% Senior Notes Due 2045 Read more about LabCorp Prices $500,000,000 in 2.625% Senior Notes Due 2020, $500,000,000 in 3.200% Senior Notes Due 2022, $1,000,000,000 in 3.600% Senior Notes Due 2025 and $900,000,000 in 4.700% Senior Notes Due 2045
LabCorp Announces Proposed Sale of Senior Notes Read more about LabCorp Announces Proposed Sale of Senior Notes
LabCorp is Scheduled to Present at the 33rd Annual J.P. Morgan Healthcare Conference Read more about LabCorp is Scheduled to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp Introduces a Test to Identify Enterovirus D-68 (EV-D68) Read more about LabCorp Introduces a Test to Identify Enterovirus D-68 (EV-D68)
LabCorp Named Laboratory Service Provider of the Pro Football Legends Read more about LabCorp Named Laboratory Service Provider of the Pro Football Legends
Hart-Scott-Rodino Waiting Period Expires for LabCorp Acquisition of Covance Read more about Hart-Scott-Rodino Waiting Period Expires for LabCorp Acquisition of Covance
LabCorp Announces Acquisition of Bode Technology Read more about LabCorp Announces Acquisition of Bode Technology
LabCorp Completes Acquisition of LIPOSCIENCE Read more about LabCorp Completes Acquisition of LIPOSCIENCE
